Regulatory Show all
February 1 | 2019

2cureX samlade ledande beslutsfattare vid New Year’s Reception

Read more
February 1 | 2019

2cureX gathered decision makers at New Year’s Reception

Read more
January 16 | 2019

2cureX strengthens the organisation via the recruitment of a CFO

Read more
January 16 | 2019

2cureX stärker organisationen genom rekrytering av CFO

Read more
December 10 | 2018

2cureX accelererar lanseringen av IndiTreat®

Read more
December 10 | 2018

2cureX is accelerating the launch of IndiTreat®

Read more
November 23 | 2018

2cureX AB offentliggör delårsrapport för januari – september 2018

Read more
November 23 | 2018

2cureX AB publishes interim report for January – September 2018

Read more
November 16 | 2018

The University Hospital, Vejle Hospital and 2cureX have received approval to start a clinical trial in pancreatic cancer

Read more
November 16 | 2018

Vejle universitetssjukhus och 2cureX har erhållit godkännande att inleda en klinisk studie i bukspottkörtelcancer

Read more
October 23 | 2018

Poster presentation at ESMO 2018 in Munich

Read more
October 23 | 2018

Presentation av poster vid ESMO 2018 i München

Read more
October 9 | 2018

2cureX meddelar godkänd CE-IVD-märkning av sitt IndiTreat-test

Read more
October 9 | 2018

2cureX announces CE-IVD marking of its IndiTreat test

Read more
October 3 | 2018

Add. info to newsletter ”2cureX GmbH receives contribution for the development of IndiTreat® tests in immuno-oncology”

Read more
October 3 | 2018

2cureX tyska dotterbolag erhåller bidrag för utveckling av IndiTreat®-test inom immunonkologi

Read more